“Our whole mantra is all about lowering costs [of infrared cameras to end customers] so that thermal imaging can be out there and everyone can own thermal imaging, because it’s still frankly a very expensive technology.” In Commercial Systems (within TVM), ASP’s (average selling price) fell by 14% per annum over the past five years; as a result, volumes increased at a pace of 27% per annum, with revenue increasing at a solid clip (double digits).
M&A – “Going forward, I wouldn’t expect us to do many more small deals and tuck in deals; we’re happy with our technology suite, we like our product suite. We’re going to be focused on building out distribution and building out channels to sell much cheaper technology, which we’re currently working on and investing in… We’re currently under a program where over the past two years we’ve been investing money to essentially come up with the next generation thermal detector that will bring the cost, to us, of that detector down by an order of magnitude. That’s extremely significant in this industry, and we think we’re well ahead of most of the competition in that space.”
MARKET SHARE – “We are number one in all of our commercial markets” – As I noted in my first article pitching FLIR, the company’s share in thermography products has been estimated by independent, third party researchers to be north of 60%, up from the mid-fifties a few years ago. Going back to the previous point outlining the virtuous cycle of volume growth and falling prices, it’s quite clear why having such outsized economies of scale are critical to success.
SHARE REPURCHASES – “We bought back 10.5 million shares last year, and we’ve already bought back 4 million this year so far; again, it’s not a trickle, scheduled thing, it’s a very opportunistic strategy”. This is music to my ears – and their historical repurchase record shows that FLIR’s management has done quite a good job of getting aggressive when Mr. Market gives them the opportunity to do so. Also, just to be clear, this spend doesn’t come at the cost of reinvestment: the company continues to target (and put up) 8-10% of sales back into R&D, as well as low-mid single digits in the form of capital expenditures.
EXPANDING GLOBAL OPPORTUNITY - “Particularly in the Middle East, there are some interesting service and sales operations there that allow us to service the Middle East customer very well, and it’s a true selling point over the competitors that we have in the space that we play there, which is mainly border security.”
FLIR’s 2012 Hiccup: after years of EPS and revenue growth (dating back to the turn of the century), what happened? 1) Manufacturing slowdown, as shown in ISM data (“Really impacts a lot of our commercial markets, particularly the thermography business”); 2) U.S. DOD budget challenges (well-known); 3) General macro (Sale of commercial products to China, one of FLIR’s largest customers, have come down a bit as the country’s GDP growth has slowed).
There wasn’t too much in Mr. Harrison’s presentation that we haven’t heard before, and things still seem to be plugging along at FLIR; U.S. Government spending will likely continue to be the primary focus of most analysts, which opens up a great opportunity for investors who can see beyond that single business line (which is declining year after year as a percentage of FLIR’s sales). I’ll have more to add when we get second quarter results at the end of next month.
About the author:I'm a value investor, with a focus on patience; I look to buy great companies that are suffering from short term issues, and hope to load up when these opportunities present themselves. As this would suggest, I run a fairly concentrated portfolio by most standards, usually with 8-10 names; from the perspective of a businessman rather than a market participant / stock trader, I believe this is more than sufficient diversification.
I hope to own a collection of great businesses; to ever sell one, I would demand a substantial premium to the average market valuation due to what I believe are the understated benefits to the long term investor of superior fundamentals and time on intrinsic value. I don't have a target when I purchase a stock; my goal is to replicate the underlying returns of the business in question - which if I've done my job properly, should be very attractive over a period of many years.